Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for reactive aggression in provocative virtual reality scenarios
NL-OMON61550Phase 2Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of propranolol (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Aggressivity during provocative virtual reality scenarios. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
propranolol
Beyond the preview
Go deeper on NL-OMON61550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61550.